Kidder Stephen W Edwards Lifesciences Corp Transaction History

Kidder Stephen W

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $373,962 - $471,225	-6,060 Reduced 46.76%	6,900 $526,000
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $34,640 - $46,690	500 Added 4.01%	12,960 $897,000
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $32,971 - $38,203	-405 Reduced 3.15%	12,460 $1.18 Million
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $155,203 - $176,625	2,090 Added 19.4%	12,865 $1.06 Million
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $653,289 - $836,363	-9,565 Reduced 47.03%	10,775 $803,000
Q3 2022 Nov 08, 2022	SELL	$82.37 - $107.29 $123,143 - $160,398	-1,495 Reduced 6.85%	20,340 $1.68 Million
Q2 2022 Jul 19, 2022	BUY	$86.5 - $128.27 $40,222 - $59,645	465 Added 2.18%	21,835 $2.08 Million
Q1 2022 May 17, 2022	BUY	$101.96 - $128.34 $461,878 - $581,380	4,530 Added 26.9%	21,370 $2.52 Million
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $716,401 - $880,129	6,735 Added 66.65%	16,840 $2.18 Million
Q3 2021 Nov 10, 2021	BUY	$102.91 - $122.75 $1.04 Million - $1.24 Million	10,105 New	10,105 $1.14 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Kidder Stephen W, based on Form 13F filings with the SEC.

Stay updated on Kidder Stephen W with notifications on news.